Allen B Reitz

Lansdale, PA, United States of America

Allen B Reitz

USPTO Granted Patents = 101 

 

 

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 394(Granted Patents)

Forward Citations (Not Self Cited) = 305(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • North Wales, PA (US) (1988)
  • Landsdale, PA (US) (2021)
  • Lansdale, PA (US) (1994 - 2024)

Company Filing History:

goldMedal22 out of 363 
 
Ortho-mcneil Pharmaceutical Corp.
 patents
silverMedal22 out of 2,077 
 
Janssen Pharmaceutica Nv
 patents
bronzeMedal12 out of 29 
 
Biohaven Therapeutics Ltd.
 patents
48 out of 8 
 
Biohaven Pharmaceutical Holding Company Limited
 patents
57 out of 188 
 
Mcneil Ab
 patents
67 out of 243 
 
The Wistar Institute
 patents
74 out of 1,455 
 
Rutgers, The State University of New Jersey
 patents
84 out of 1,187 
 
The Scripps Research Institute
 patents
93 out of 377 
 
Ortho Pharmaceutical Corporation
 patents
103 out of 10 
 
Oligomerix, Inc.
 patents
112 out of 173 
 
Musc Foundation for Research Development
 patents
122 out of 2,596 
 
University of Pennsylvania
 patents
131 out of 271 
 
Johnson & Johnson Consumer Companies, Inc.
 patents
141 out of 1 
 
Leukogene Therapeutics Incorporated
 patent
151 out of 3 
 
Pfizer Ireland Pharmaceuticals
 patents
161 out of 1 
 
Lukogene Therapeutics Incorporated
 patent
171 out of 1,325 
 
Yale University
 patents
181 out of 2 
 
Kleo Pharmaceuticals, Inc.
 patents
191 out of 1 
 
Fox Chase Chemical Diversity Center, Inc.
 patent
201 out of 1 
 
Advanced Neural Dynamics, Inc.
 patent
211 out of 1 
 
Ncneilab, Inc.
 patent
224 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Riluzole Prodrugs
EBNA1 Inhibitors
Tau Oligomer Inhibitors
CGRP Antagonists
Antibody-Recruiting Molecules
Antiviral Compounds
Benzo-Fused Heterocycles
DPP-1 Inhibitors
Neuroprotective Action
Melanocortin Receptor Modulators
BACE Inhibitors
Sulfamate Derivatives
101 patents (USPTO):Explore Patents

Title: Allen B Reitz: Pioneering Innovator in the Field of Pharmaceuticals

Introduction:

In the domain of pharmaceuticals, exceptional individuals like Allen B Reitz have made groundbreaking contributions by developing innovative compounds and inventions to combat diseases. With an impressive portfolio of patents and a notable career history, Allen B Reitz has earned recognition as a pioneering innovator. This article explores some of his latest patents, career highlights, and collaborations, shedding light on his remarkable achievements.

Latest Patents:

Allen B Reitz's latest patents demonstrate his ingenuity and dedication to finding solutions for challenging medical conditions. One of his recent inventions is centered around indene derivatives and their potential use in the treatment of cancer. These compounds, formulated based on formula (I), exhibit promising properties for combating this deadly disease.

In addition, Reitz has invented novel quinazolinones that inhibit the formation of tau oligomers, which play a crucial role in neurodegenerative diseases. These compounds offer potential therapeutic benefits for the treatment of neurodegenerative conditions, representing a significant breakthrough in the field. Reitz's patents also cover the preparation of these compounds, their intermediates, and pharmaceutical compositions comprising them.

Career Highlights:

Throughout his career, Allen B Reitz has left an indelible mark within the pharmaceutical industry. He has worked diligently for renowned companies, including Janssen Pharmaceutica N.V. and Ortho-McNeil Pharmaceutical Corp., where he contributed significantly to research and development efforts. Reitz's expertise and dedication have propelled him forward, resulting in an impressive portfolio of 83 patents.

Collaborations:

Within the collaborative realm, Allen B Reitz has had the opportunity to work with accomplished professionals who share his passion for scientific exploration. Notable colleagues such as Garry Robert Smith and Tina Morgan Ross have joined forces with Reitz to strive for advancements in pharmaceutical research. Collaborations such as these have fostered a fertile environment for innovative ideas and expedited the development of novel inventions.

Conclusion:

Allen B Reitz stands as an exemplary figure in the field of pharmaceuticals, highlighting the power of innovation and ingenuity in battling diseases. His latest patents, focused on developing effective treatments for cancer and neurodegenerative conditions, portray his commitment to improving the lives of patients worldwide. With an extensive career history and influential collaborations, Reitz's contributions have made a lasting impact on the pharmaceutical industry. As we look ahead to the future, we eagerly anticipate the next wave of innovations from visionaries like Allen B Reitz.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…